These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16492074)

  • 1. Trachoma and the need for a coordinated community-wide response: a case-based study.
    Wright HR; Keeffe JE; Taylor HR
    PLoS Med; 2006 Feb; 3(2):e41; quiz e155. PubMed ID: 16492074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for trachoma.
    Prescrire Int; 2009 Aug; 18(102):176-7. PubMed ID: 19750586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should trachoma be treated with antibiotics?
    Dawson CR; Schachter J
    Lancet; 2002 Jan; 359(9302):184-5. PubMed ID: 11812548
    [No Abstract]   [Full Text] [Related]  

  • 4. New steps toward eliminating blinding trachoma.
    Mariotti SP
    N Engl J Med; 2004 Nov; 351(19):2004-7. PubMed ID: 15525727
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin for the treatment and control of trachoma.
    Burton MJ; Frick KD; Bailey RL; Bowman RJ
    Expert Opin Pharmacother; 2002 Feb; 3(2):113-20. PubMed ID: 11829725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trachoma and Yaws: Common Ground?
    Solomon AW; Marks M; Martin DL; Mikhailov A; Flueckiger RM; Mitjà O; Asiedu K; Jannin J; Engels D; Mabey DC
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004071. PubMed ID: 26633176
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of trachoma in chronic conjunctivitis, Birjand, Islamic Republic of Iran.
    Yaqubi GH; Anani GR
    East Mediterr Health J; 2002; 8(2-3):350-3. PubMed ID: 15339124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milestones in the fight to eliminate trachoma.
    West SK
    Ophthalmic Physiol Opt; 2020 Mar; 40(2):66-74. PubMed ID: 32017172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin treatment levels inadequate for recommended trachoma control guidelines.
    Kelaher M; Ferdinand AS; Taylor HR
    Med J Aust; 2011 Jan; 194(2):102. PubMed ID: 21241228
    [No Abstract]   [Full Text] [Related]  

  • 12. WHO alliance for the global elimination of blinding trachoma and the potential use of azithromycin.
    Négrel AD; Mariotti SP
    Int J Antimicrob Agents; 1998 Nov; 10(4):259-62. PubMed ID: 9916898
    [No Abstract]   [Full Text] [Related]  

  • 13. Active trachoma two years after three rounds of azithromycin mass treatment in Cheha District Gurage Zone, Southern Ethiopia.
    Admassu F; Bayu S; Bejiga A; Amare B
    BMC Pediatr; 2013 Dec; 13():199. PubMed ID: 24289535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow resolution of clinically active trachoma following successful mass antibiotic treatments.
    Keenan JD; Lakew T; Alemayehu W; Melese M; House JI; Acharya NR; Porco TC; Gaynor BD; Lietman TM
    Arch Ophthalmol; 2011 Apr; 129(4):512-3. PubMed ID: 21482879
    [No Abstract]   [Full Text] [Related]  

  • 15. Stopping azithromycin mass drug administration for trachoma: A systematic review.
    Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.
    Nash SD; Stewart AEP; Astale T; Sata E; Zerihun M; Gessese D; Melak B; Ayenew G; Ayele Z; Bayissasse B; Chanyalew M; Tadesse Z; Callahan EK
    Trans R Soc Trop Med Hyg; 2018 Dec; 112(12):538-545. PubMed ID: 30265355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Trachoma in Pakistan: Results of 42 Population-Based Prevalence Surveys from the Global Trachoma Mapping Project.
    Khan AA; Florea VV; Hussain A; Jadoon Z; Boisson S; Willis R; Dejene M; Bakhtiari A; Mpyet C; Pavluck AL; Gillani M; Qureshi B; Solomon AW
    Ophthalmic Epidemiol; 2020 Apr; 27(2):155-164. PubMed ID: 31916887
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.
    Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC
    Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
    Atik B; Thanh TT; Luong VQ; Lagree S; Dean D
    JAMA; 2006 Sep; 296(12):1488-97. PubMed ID: 17003397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of azithromycin for the control of trachoma in Northern Tanzania.
    Desmond N; Solomon AW; Massae PA; Lema N; Anemona A; Foster A; Mabey DC
    Trans R Soc Trop Med Hyg; 2005 Sep; 99(9):656-63. PubMed ID: 15979657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.